Visual field loss associated with vigabatrin: Quantification and relation to dosage

Epilepsia

Volumn 42, Issue 2, 2001, Pages 262-267

  Hardus, P ^a   Verduin, W M ^b   Engelsman, M ^c   Edelbroek, P M ^c   Segers, J P ^c   Berendschot, T T J M ^b   Stilma, J S ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

AED; Compliance; Cumulative dose of vigabatrin; Epilepsy; Visual field loss

Indexed keywords

ANTICONVULSIVE AGENT; VIGABATRIN;

ADULT; ANAMNESIS; ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG SAFETY; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; VISUAL FIELD DEFECT;

ADULT; AMBULATORY CARE; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PERIMETRY; REGRESSION ANALYSIS; SEX FACTORS; VIGABATRIN; VISION DISORDERS; VISUAL FIELDS;

EID: 0035097765     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.15000.x     Document Type: Article

References (26)

1. Severe persistent visual field constriction associated with vigabatrin
2. Asymptomatic as well as symptomatic defects occur with vigabatrin
3. Severe persistent visual field constriction associated with vigabatrin
4. Severe persistent visual field constriction associated with vigabatrin
5. Severe persistent visual field constriction associated with vigabatrin
6. Electrooculography, ERGs, multifocal ERGs and VEPs in epileptic patients showing visual field disorders
7. Vigabatrin-associated bilateral concentric visual field defects in four patients
8. Vigabatrin-associated retinal cone systems dysfunction: Electroretinogram and ophthalmologic findings
9. Visual field constriction in children treated with vigabatrin
10. Electrophysiologic evaluation of a patient with peripheral field contraction associated with vigabatrin
11. Symptomatic and asymptomatic visual loss in patients taking vigabatrin
12. Outer retinal dysfunction in patients treated with vigabatrin
13. Visual field defects associated with vigabatrin study
14. Characteristics of a unique visual field defect attributed to vigabatrin
15. Visual dysfunction in patients receiving vigabatrin
16. Concentric contraction of the visual field in patients with temporal lobe epilepsy and its association with the use of vigabatrin medication
17. Long term changes of the visual field in patients with temporal lobe epilepsy using vigabatrin
18. Grids for scoring visual fields. II. Perimeter
19. Vigabatrin, a GABAergic epileptic drug, causes concentric visual field defects
20. Vigabatrin: Chemistry, absorption, distribution, and elimination
21. Vigabatrin serum concentration to dosage ratio: Influence of age and associated antiepileptic drugs
22. Aspects of visual field loss associated with vigabatrin. Vigabatrin: Current status and future prospects
23. Evaluating the usefulness in neuro-ophthalmology of visual field examinations peripheral to 30 degrees
24. The visual field of patients with pseudophakia using kinetic and automated perimetry
25. The visual field of pseudophakic patients: Perimetric and statistical study
26. Is the devil we know the lesser of the two devils? Vigabatrin and visual fields